USD948704S1 - Inhaler - Google Patents

Inhaler Download PDF

Info

Publication number
USD948704S1
USD948704S1 US29/699,563 US201929699563F USD948704S US D948704 S1 USD948704 S1 US D948704S1 US 201929699563 F US201929699563 F US 201929699563F US D948704 S USD948704 S US D948704S
Authority
US
United States
Prior art keywords
inhaler
view
side perspective
ornamental design
design
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/699,563
Inventor
Mukul DALVI
Imran Shaikh
Xian-Ming Zeng
Antonio Belton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lupin Ltd
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Priority to US29/699,563 priority Critical patent/USD948704S1/en
Assigned to LUPIN INC reassignment LUPIN INC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DALVI, MUKUL, SHAIKH, IMRAN, ZENG, XIAN-MING, BELTON, ANTONIO
Assigned to LUPIN LTD. reassignment LUPIN LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: Lupin Inc.
Priority to JPD2020-1213F priority patent/JP1669002S/ja
Priority to CL2020000212F priority patent/CL2020000212S1/en
Application granted granted Critical
Publication of USD948704S1 publication Critical patent/USD948704S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a left side perspective view of an inhaler, showing our new design;
FIG. 2 is a right side perspective view thereof;
FIG. 3 is a front view thereof;
FIG. 4 is a rear view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a right side view thereof;
FIG. 7 is a top view thereof;
FIG. 8 is a bottom view thereof;
FIG. 9 is a left side perspective view thereof in an open configuration;
FIG. 10 is a right side perspective view thereof;
FIG. 11 is a front view thereof;
FIG. 12 is a rear view thereof;
FIG. 13 is a left side view thereof;
FIG. 14 is a right side view thereof;
FIG. 15 is a top view thereof; and,
FIG. 16 is a bottom view thereof.
Where portions shown in broken lines form no part of the claimed design.

Claims (1)

    CLAIM
  1. We claim, the ornamental design for an inhaler, as shown and described.
US29/699,563 2019-07-26 2019-07-26 Inhaler Active USD948704S1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US29/699,563 USD948704S1 (en) 2019-07-26 2019-07-26 Inhaler
JPD2020-1213F JP1669002S (en) 2019-07-26 2020-01-24
CL2020000212F CL2020000212S1 (en) 2019-07-26 2020-01-24 Inhaler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/699,563 USD948704S1 (en) 2019-07-26 2019-07-26 Inhaler

Publications (1)

Publication Number Publication Date
USD948704S1 true USD948704S1 (en) 2022-04-12

Family

ID=70848285

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/699,563 Active USD948704S1 (en) 2019-07-26 2019-07-26 Inhaler

Country Status (3)

Country Link
US (1) USD948704S1 (en)
JP (1) JP1669002S (en)
CL (1) CL2020000212S1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD977627S1 (en) * 2019-02-04 2023-02-07 Orion Corporation Inhaler
USD983961S1 (en) * 2020-02-14 2023-04-18 Aptar France Sas Inhaler
USD995752S1 (en) * 2020-02-14 2023-08-15 Aptar France Sas Inhaler
USD1006214S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler
USD1006213S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020073996A1 (en) * 2000-06-23 2002-06-20 O'leary David Dose counter for medicament inhaler
US20060237009A1 (en) * 2003-02-11 2006-10-26 Jones Matthew M Dispensing apparatus
US20150099726A1 (en) * 2013-10-07 2015-04-09 Teva Branded Pharmaceutical Products R&D, Inc. Dry powder inhaler
USD769437S1 (en) * 2013-11-29 2016-10-18 Norton (Waterford) Limited Respiratory apparatus
US20160303336A1 (en) * 2013-12-09 2016-10-20 Pharmachemie B.V. Dry powder inhaler
USD783151S1 (en) * 2013-10-07 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD783150S1 (en) * 2013-10-07 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD808515S1 (en) * 2016-04-05 2018-01-23 3M Innovative Properties Company Inhaler
US20190111221A1 (en) * 2016-04-05 2019-04-18 3M Innovative Properties Company Medicinal inhaler refill assemblies comprising a lockout mechanism
US20200046916A1 (en) * 2017-04-25 2020-02-13 3M Innovative Properties Company Medicinal inhaler comprising a lockout override mechanism

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020073996A1 (en) * 2000-06-23 2002-06-20 O'leary David Dose counter for medicament inhaler
US20060237009A1 (en) * 2003-02-11 2006-10-26 Jones Matthew M Dispensing apparatus
US20150099726A1 (en) * 2013-10-07 2015-04-09 Teva Branded Pharmaceutical Products R&D, Inc. Dry powder inhaler
USD783151S1 (en) * 2013-10-07 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD783150S1 (en) * 2013-10-07 2017-04-04 Teva Pharmaceutical Industries Limited Respiratory apparatus
USD769437S1 (en) * 2013-11-29 2016-10-18 Norton (Waterford) Limited Respiratory apparatus
US20160303336A1 (en) * 2013-12-09 2016-10-20 Pharmachemie B.V. Dry powder inhaler
USD808515S1 (en) * 2016-04-05 2018-01-23 3M Innovative Properties Company Inhaler
USD834704S1 (en) * 2016-04-05 2018-11-27 3M Innovative Properties Company Inhaler
US20190111221A1 (en) * 2016-04-05 2019-04-18 3M Innovative Properties Company Medicinal inhaler refill assemblies comprising a lockout mechanism
US11110234B2 (en) * 2016-04-05 2021-09-07 Kindeva Drug Delivery L.P. Medicinal inhaler refill assemblies comprising a lockout mechanism
US20200046916A1 (en) * 2017-04-25 2020-02-13 3M Innovative Properties Company Medicinal inhaler comprising a lockout override mechanism

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD977627S1 (en) * 2019-02-04 2023-02-07 Orion Corporation Inhaler
USD982735S1 (en) * 2019-02-04 2023-04-04 Orion Corporation Inhaler
USD986407S1 (en) * 2019-02-04 2023-05-16 Orion Corporation Inhaler
USD983961S1 (en) * 2020-02-14 2023-04-18 Aptar France Sas Inhaler
USD995752S1 (en) * 2020-02-14 2023-08-15 Aptar France Sas Inhaler
USD1006214S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler
USD1006213S1 (en) * 2020-02-14 2023-11-28 Aptar France Sas Inhaler

Also Published As

Publication number Publication date
CL2020000212S1 (en) 2020-05-15
JP1669002S (en) 2020-09-28

Similar Documents

Publication Publication Date Title
USD890724S1 (en) Earphone
USD895207S1 (en) Epilator
USD905901S1 (en) Electronic cigarette
USD903638S1 (en) Earphone
USD885373S1 (en) Headphone
USD863265S1 (en) Earphone
USD895206S1 (en) Epilator
USD853357S1 (en) Earphone cover
USD927056S1 (en) E-cigarette
USD879067S1 (en) Earphones
USD888934S1 (en) Nebulizer
USD920959S1 (en) Earphone
USD896436S1 (en) Atomizer
USD879072S1 (en) Speaker
USD888932S1 (en) Inhaler
USD880765S1 (en) Nicotine inhaler
USD910593S1 (en) Headphones
USD910908S1 (en) Electronic cigarette
USD894261S1 (en) Guitar
USD948704S1 (en) Inhaler
USD948703S1 (en) Inhaler
USD883254S1 (en) Rear surround speaker
USD926059S1 (en) Alcoholometer
USD897236S1 (en) Hoverboard
USD898709S1 (en) Earphone

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY